95 related articles for article (PubMed ID: 12161856)
1. Nandrolone (Deca Durabolin) disappears in U.S., generic may return in July.
James JS
AIDS Treat News; 2002 Jun; (381):3-4, 1. PubMed ID: 12161856
[TBL] [Abstract][Full Text] [Related]
2. The end of nandrolone.
Vergel N
GMHC Treat Issues; 2007; 21(1):1-3. PubMed ID: 17722330
[No Abstract] [Full Text] [Related]
3. Treatment for HIV wasting withdrawn.
Huff B
GMHC Treat Issues; 2002 Jun; 16(6):10-1. PubMed ID: 12141285
[No Abstract] [Full Text] [Related]
4. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
Saha B; Rajadhyaksha GC; Ray SK
J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
[TBL] [Abstract][Full Text] [Related]
7. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
8. A comparison of drostanolone propionate (Masteril) and nandrolone decanoate (Deca-durabolin) in the treatment of breast carcinoma.
Chowdhury MS; Banks AJ; Bond WH; Jones WG; Ward HW
Clin Oncol; 1976 Sep; 2(3):203-6. PubMed ID: 1036981
[No Abstract] [Full Text] [Related]
9. Anabolic steroid boosts weight.
GMHC Treat Issues; 1996 Sep; 10(9):8-9. PubMed ID: 11363845
[TBL] [Abstract][Full Text] [Related]
10. Nandrolone: generic now in stock.
AIDS Treat News; 2002 Aug; (382):5. PubMed ID: 12236206
[No Abstract] [Full Text] [Related]
11. Treatment. Court decision to allow marketing of generic form of weight-loss drug.
AIDS Policy Law; 2001 Aug; 16(14):4. PubMed ID: 11548472
[No Abstract] [Full Text] [Related]
12. Generic low-molecular-weight heparins: some practical considerations.
Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
[TBL] [Abstract][Full Text] [Related]
13. Medicaid provider trumps physician over HIV wasting drug.
AIDS Policy Law; 2006 Dec; 21(22):3. PubMed ID: 17274135
[No Abstract] [Full Text] [Related]
14. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
[TBL] [Abstract][Full Text] [Related]
15. Global AIDS trial denied patients as US balks at generic drug use.
Check E
Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
[No Abstract] [Full Text] [Related]
16. Study: U.S. generic drugs cost less then Canadian drugs.
Bren L
FDA Consum; 2004; 38(4):9. PubMed ID: 15346576
[TBL] [Abstract][Full Text] [Related]
17. International. Rights group: U.S. blocking access to generic AIDS drugs.
AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
[No Abstract] [Full Text] [Related]
18. Generic drugs allowed in global trial of AIDS therapy.
Check E
Nature; 2004 Oct; 431(7012):1028. PubMed ID: 15510113
[No Abstract] [Full Text] [Related]
19. [Clinical and biochemical effects of nandrolone phenilpropionate (durabolin) and nandrolone decanoate (deca-durabolin) in diabetic retinopathies].
HOUTSMULLER AJ; HENKES HE
Ber Zusammenkunft Dtsch Ophthalmol Ges; 1961; 63():57-62. PubMed ID: 14449333
[No Abstract] [Full Text] [Related]
20. Counteracting muscle wasting in HIV-infected individuals.
Dudgeon WD; Phillips KD; Carson JA; Brewer RB; Durstine JL; Hand GA
HIV Med; 2006 Jul; 7(5):299-310. PubMed ID: 16945075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
